We are pleased that you have found your way to our information point, and we would like to offer you a warm welcome. Carcinoid call-point gGmbH is a non-profit company, and operates on the basis of the concept of self-help. We are concerned specifically with neuroendocrine tumours.
We have set ourselves the goal of informing the general public, sufferers, relatives and friends about all aspects of this rare form of tumour, and in this way to help in the management of the disease.
The shareholders and staff of Carcinoid call-point gGmbH aim to help you find the information you need, and to share our experiences with you. We believe that comprehensive information and seriously-minded support are important conditions for the ability to combat anxiety and make it possible to take meaningful steps against the disease.
The non-profit company Carcinoid call-point gGmbH is registered in the official company register of Charlottenburg on 9 April 2006 under the registration number:
B 100872 and has its headquarters in Berlin. It is recognised as a charity by the local tax office for corporations.
In pursuance of these aims we will make information available to sufferers, relatives and friends on:
- current developments in research
- diagnosis
- technology
- current studies
- specialist clinics in the Federal Republic of Germany
- office-based medical specialists in your immediate neighbourhood
- physicians and other contact partners in the field of healthcare
- patient seminars nationwide
We cooperate with self-help groups and establish contact between patients and self-help groups.
We offer sufferers, their relatives and friends, support in:
- questions relating to the takeover of costs by funding bodies
- locating suitable after-care
- psychological treatment and care
Our regular information and support will be provided by means of:
- up-to-date publications
- internet site in three languages
- newspaper Carcinoid call-point gGmbH all about NET
- daily access by telephone
- and the establishment of an emergency service










